Review
doi: 10.1146/annurev.pu.13.050192.002151.
Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals
Affiliations
- PMID: 1599596
- DOI: 10.1146/annurev.pu.13.050192.002151
Item in Clipboard
Review
Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals
Annu Rev Public Health.
1992.
No abstract available
Similar articles
-
A critical analysis of studies of state drug reimbursement policies: research in need of discipline.Milbank Q. 1993;71(2):217-52. Milbank Q. 1993. PMID: 8510601
-
States exempt psychiatric drugs in some Medicaid programs.Manag Care. 2003 Nov;12(11):61. Manag Care. 2003. PMID: 14666588 No abstract available.
-
States' control of prescription drug spending: a heterogeneous approach.Health Aff (Millwood). 2005 Jul-Aug;24(4):1032-8. doi: 10.1377/hlthaff.24.4.1032. Health Aff (Millwood). 2005. PMID: 16012143
-
Medicaid physician participation: patients, poverty, and physician self-interest.Am J Law Med. 1995;21(2-3):191-220. Am J Law Med. 1995. PMID: 8571975 Review. No abstract available.
-
Medicaid formularies: a critical review of the literature.J Pharm Mark Manage. 1988 Spring;2(3):39-61. doi: 10.3109/j058v02n03_05. J Pharm Mark Manage. 1988. PMID: 10302873 Review.
Cited by
-
Self-restriction of medications due to cost in seniors without prescription coverage.J Gen Intern Med. 2001 Dec;16(12):793-9. doi: 10.1111/j.1525-1497.2001.10412.x. J Gen Intern Med. 2001. PMID: 11903757 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
